APRISO is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Mesalamine.
| Product ID | 43353-884_08025228-3c71-400b-95ff-80d6aea38f33 |
| NDC | 43353-884 |
| Product Type | Human Prescription Drug |
| Proprietary Name | APRISO |
| Generic Name | Mesalamine |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-10-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022301 |
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
| Substance Name | MESALAMINE |
| Active Ingredient Strength | 375 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-02-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022301 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-02-17 |
| Ingredient | Strength |
|---|---|
| MESALAMINE | 375 mg/1 |
| SPL SET ID: | faaaa4b7-087e-4c50-820d-561f8f39adc8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43353-884 | APRISO | APRISO |
| 65649-103 | APRISO | APRISO |
| 0023-5901 | Asacol HD | mesalamine |
| 0430-0783 | ASACOL HD | mesalamine |
| 0023-5853 | Delzicol | mesalamine |
| 0179-0142 | Lialda | mesalamine |
| 0093-5907 | Mesalamine | Mesalamine |
| 0093-9224 | mesalamine | mesalamine |
| 0378-1375 | Mesalamine | mesalamine |
| 0378-9230 | Mesalamine | mesalamine |
| 0472-1915 | Mesalamine | Mesalamine |
| 0037-0066 | Rowasa | mesalamine |
| 0037-0022 | sfRowasa | mesalamine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() APRISO 77520068 3743051 Live/Registered |
Salix Pharmaceuticals, Ltd. 2008-07-11 |
![]() APRISO 76333591 2682873 Live/Registered |
APRISO CORP. 2001-11-02 |